This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Bloodwise (charity) | |
|---|---|
| Name | Bloodwise |
| Formation | 1960 |
| Type | Charity |
| Status | Registered charity |
| Purpose | Funding research into leukemia, lymphoma and myeloma |
| Headquarters | London, England |
| Region served | United Kingdom |
| Leader title | Chief Executive |
| Leader name | (see Governance and Funding) |
| Website | (omitted) |
Bloodwise (charity) is a United Kingdom-based medical research charity focused on blood cancers including leukemia, lymphoma and myeloma. Founded in the 20th century, the organisation funds biomedical research, supports clinical trials, and runs national fundraising and awareness campaigns. It engages with patients, clinicians, academic institutions and policy makers to translate laboratory discoveries into treatments.
The organisation traces roots to post-war medical movements and patient advocacy linked to figures such as Aneurin Bevan, Winston Churchill era health reforms and foundations influenced by charitable activity in London, Manchester, Glasgow and Birmingham. Early links included partnerships with hospitals like St Thomas' Hospital, Royal Marsden Hospital, Guy's Hospital and university departments at University of Oxford, University of Cambridge, University College London and Imperial College London. During the late 20th century the charity intersected with national initiatives such as the National Health Service reforms, collaborations with research councils like the Medical Research Council and funders including Wellcome Trust and private benefactors from the worlds of City of London philanthropy and foundations such as the Gates Foundation influence. The charity's history also reflects engagement with clinical leaders from centres such as Addenbrooke's Hospital, Royal Free Hospital and international centres like Mayo Clinic and Dana–Farber Cancer Institute.
The charity’s mission aligns with translational medicine priorities set by institutions like Francis Crick Institute and aligns with standards from regulatory bodies including NHS England and European Medicines Agency. Activities span grantmaking to research groups at University of Edinburgh, University of Manchester, King's College London, and specialist units such as Great Ormond Street Hospital and Royal Infirmary of Edinburgh. They support patient services comparable to those at Macmillan Cancer Support and Marie Curie while collaborating with professional societies such as British Society for Haematology, Royal College of Physicians, Institute of Cancer Research and networks like Clinical Trials Units. The charity communicates through channels used by organisations such as BBC and The Guardian to reach donors and patients.
Funding priorities reflect outcomes promoted by groups such as National Institute for Health and Care Excellence, European Society for Medical Oncology, American Society of Hematology and align with translational pipelines at centres like Stanford University, Harvard Medical School, University of California, San Francisco and European universities including Karolinska Institute and Heidelberg University Hospital. Research grants support basic science in laboratories using techniques from CRISPR research communities, genomics programmes influenced by the Human Genome Project and proteomics platforms at institutions such as EMBL-EBI. Clinical trials are run in collaboration with NHS trusts, academic trial units and international consortia such as those linked to European Organisation for Research and Treatment of Cancer and US National Cancer Institute. Projects have targeted targeted therapies inspired by work at Gustave Roussy, immunotherapy approaches following breakthroughs at University of Pennsylvania and cell therapies akin to developments at Fred Hutchinson Cancer Center.
Fundraising activities mirror models used by charities such as Cancer Research UK, British Heart Foundation, Oxfam and Save the Children. National campaigns include public appeals, peer-to-peer events similar to Great Ormond Street Hospital fundraisers, challenge events like marathons associated with London Marathon, community collections in partnership with supermarkets found across Tesco and Sainsbury's branches, and corporate partnerships with firms in City of London and multinational companies headquartered in London and Edinburgh. High-profile patronage has historically involved public figures, broadcasters from BBC Television Centre and personalities known from Coronation Street and EastEnders appearances to increase visibility.
The charity engages with policy processes connected to institutions such as Department of Health and Social Care, Parliament of the United Kingdom, Scottish Parliament, Welsh Government and Northern Ireland Assembly, working alongside patient organisations like Macmillan Cancer Support and professional organisations such as Royal College of Nursing. Advocacy focuses on access to therapies evaluated by National Institute for Health and Care Excellence, equitable commissioning across Clinical Commissioning Group predecessors and NHS England specialised commissioning frameworks. The organisation has contributed evidence to inquiries and consultations alongside academics from London School of Hygiene & Tropical Medicine and King's Fund.
Governance follows charity law in the United Kingdom with oversight similar to organisations regulated by the Charity Commission for England and Wales. Boards have included trustees drawn from sectors represented by Institute of Directors, senior clinicians from Royal College of Pathologists and executives with experience at companies listed on London Stock Exchange. Funding sources include public donations, legacies, corporate sponsorship, grants from research funders such as Cancer Research UK and partnerships with philanthropic foundations like Wellcome Trust and family foundations active across Europe and North America.
Partnerships span academic institutions including University of Birmingham, Queen Mary University of London, Newcastle University and international collaborators at University of Toronto, University of Melbourne and Instituto de Salud Carlos III. Collaborations with biotech and pharmaceutical companies reflect engagement with firms with pipelines in hematology and oncology, often operating in ecosystems around Cambridge and Oxford science parks. Impact is measured through peer-reviewed publications in journals such as The Lancet, Nature, Blood (journal), New England Journal of Medicine and through contributions to treatment guidelines from bodies like NICE and European Medicines Agency committees.
Category:Health charities in the United Kingdom Category:Cancer organisations based in the United Kingdom